Scherrer C, Loret C, Vedrenne N, Buckley C, Lia A, Kermene V
J Tissue Eng. 2025; 16:20417314241310508.
PMID: 40078221
PMC: 11898049.
DOI: 10.1177/20417314241310508.
Puranik N, Song M
Biomolecules. 2024; 14(9).
PMID: 39334827
PMC: 11430182.
DOI: 10.3390/biom14091060.
Matsumoto Y, Miwa H, Katayama K, Watanabe A, Yamada K, Ito T
Front Mol Neurosci. 2024; 17:1386924.
PMID: 38736483
PMC: 11082273.
DOI: 10.3389/fnmol.2024.1386924.
Gazzola M, Martinat C
Int J Mol Sci. 2023; 24(20).
PMID: 37894969
PMC: 10607237.
DOI: 10.3390/ijms242015291.
Berenger-Currias N, Martinat C, Baghdoyan S
Cells. 2023; 12(4).
PMID: 36831237
PMC: 9954118.
DOI: 10.3390/cells12040571.
MBNL-dependent impaired development within the neuromuscular system in myotonic dystrophy type 1.
Tahraoui-Bories J, Merien A, Gonzalez-Barriga A, Laine J, Leteur C, Polveche H
Neuropathol Appl Neurobiol. 2022; 49(1):e12876.
PMID: 36575942
PMC: 10107781.
DOI: 10.1111/nan.12876.
Slitrk2 deficiency causes hyperactivity with altered vestibular function and serotonergic dysregulation.
Katayama K, Morimura N, Kobayashi K, Corbett D, Okamoto T, Ornthanalai V
iScience. 2022; 25(7):104604.
PMID: 35789858
PMC: 9250022.
DOI: 10.1016/j.isci.2022.104604.
Cell type-specific abnormalities of central nervous system in myotonic dystrophy type 1.
Nakamori M, Shimizu H, Ogawa K, Hasuike Y, Nakajima T, Sakurai H
Brain Commun. 2022; 4(3):fcac154.
PMID: 35770133
PMC: 9218787.
DOI: 10.1093/braincomms/fcac154.
Understanding the Molecular Basis of Fragile X Syndrome Using Differentiated Mesenchymal Stem Cells.
Fazeli Z, Ghaderian S, Najmabadi H, Omrani M
Iran J Child Neurol. 2022; 16(1):85-95.
PMID: 35222660
PMC: 8753000.
DOI: 10.22037/ijcn.v15i4.22070.
DM1 Transgenic Mice Exhibit Abnormal Neurotransmitter Homeostasis and Synaptic Plasticity in Association with RNA Foci and Mis-Splicing in the Hippocampus.
Potier B, Lallemant L, Parrot S, Huguet-Lachon A, Gourdon G, Dutar P
Int J Mol Sci. 2022; 23(2).
PMID: 35054778
PMC: 8775431.
DOI: 10.3390/ijms23020592.
Brain Pathogenesis and Potential Therapeutic Strategies in Myotonic Dystrophy Type 1.
Liu J, Guo Z, Yan X, Yang Y, Huang S
Front Aging Neurosci. 2021; 13:755392.
PMID: 34867280
PMC: 8634727.
DOI: 10.3389/fnagi.2021.755392.
Optogenetically controlled human functional motor endplate for testing botulinum neurotoxins.
Duchesne de Lamotte J, Polentes J, Roussange F, Lesueur L, Feurgard P, Perrier A
Stem Cell Res Ther. 2021; 12(1):599.
PMID: 34865655
PMC: 8647380.
DOI: 10.1186/s13287-021-02665-3.
Identification of cerebrospinal fluid biomarkers for parkinsonism using a proteomics approach.
Marques T, van Rumund A, Kersten I, Bruinsma I, Wessels H, Gloerich J
NPJ Parkinsons Dis. 2021; 7(1):107.
PMID: 34848724
PMC: 8633286.
DOI: 10.1038/s41531-021-00249-9.
Neuromuscular Development and Disease: Learning From and Models.
Fralish Z, Lotz E, Chavez T, Khodabukus A, Bursac N
Front Cell Dev Biol. 2021; 9:764732.
PMID: 34778273
PMC: 8579029.
DOI: 10.3389/fcell.2021.764732.
Emerging Opportunities in Human Pluripotent Stem-Cells Based Assays to Explore the Diversity of Botulinum Neurotoxins as Future Therapeutics.
Duchesne de Lamotte J, Perrier A, Martinat C, Nicoleau C
Int J Mol Sci. 2021; 22(14).
PMID: 34299143
PMC: 8308099.
DOI: 10.3390/ijms22147524.
Transcriptional-regulatory convergence across functional MDD risk variants identified by massively parallel reporter assays.
Mulvey B, Dougherty J
Transl Psychiatry. 2021; 11(1):403.
PMID: 34294677
PMC: 8298436.
DOI: 10.1038/s41398-021-01493-6.
Current Progress in the Creation, Characterization, and Application of Human Stem Cell-derived in Vitro Neuromuscular Junction Models.
Lynch E, Peek E, Reilly M, FitzGibbons C, Robertson S, Suzuki M
Stem Cell Rev Rep. 2021; 18(2):768-780.
PMID: 34212303
PMC: 8720113.
DOI: 10.1007/s12015-021-10201-2.
Human brain pathology in myotonic dystrophy type 1: A systematic review.
Weijs R, Okkersen K, van Engelen B, Kusters B, Lammens M, Aronica E
Neuropathology. 2021; 41(1):3-20.
PMID: 33599033
PMC: 7986875.
DOI: 10.1111/neup.12721.
hiPSC-Derived Neurons Provide a Robust and Physiologically Relevant Platform to Test Botulinum Neurotoxins.
Duchesne de Lamotte J, Roqueviere S, Gautier H, Raban E, Boure C, Fonfria E
Front Pharmacol. 2021; 11:617867.
PMID: 33519485
PMC: 7840483.
DOI: 10.3389/fphar.2020.617867.
Induced Pluripotent Stem Cells to Understand Mucopolysaccharidosis. I: Demonstration of a Migration Defect in Neural Precursors.
Lito S, Sidibe A, Ilmjarv S, Burda P, Baumgartner M, Wehrle-Haller B
Cells. 2020; 9(12).
PMID: 33287330
PMC: 7761689.
DOI: 10.3390/cells9122593.